GUANGZHOU, CHINA, January 5, 2018 –
Bio-Thera Solutions, a clinical-stage biopharmaceutical company
developing a pipeline of innovative oncology therapies as well as a
pipeline of biosimilars, today announced that Bert Thomas, PhD, MBA,
Bio-Thera’s Senior Vice President of Business Development, will present a
corporate overview at Biotech Showcase 2018 on January 10th, 2018 at 11:00 AM Pacific Time. The conference will be held at the Hilton San Francisco Union Square in San Francisco, CA.
About Bio-Thera Solutions
Bio-Thera
Solutions is a clinical-stage biopharmaceutical company focused on
innovative oncology therapeutics and biosimilars. Bio-Thera is
developing a pipeline on antibody-drug conjugates and enhanced
monoclonal antibodies for the treatment of a broad range of cancers and
other diseases. Bio-Thera’s biosimilar pipeline is focused on
autoimmune and oncology therapeutics. The company is headquartered in
Guangzhou, China and has more than 300 employees. Learn more at http://www.hengji-steel.com/EN/. Follow Bio-Thera Solutions on Twitter at @bio_thera_sol
